# A Phase I Trial to Investigate the Safety and Tolerability of PF-06649751

> **NCT01981694** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-06649751
- **DRUG:** PF-06649751

## Key facts

- **NCT ID:** NCT01981694
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2014-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01981694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01981694, "A Phase I Trial to Investigate the Safety and Tolerability of PF-06649751". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01981694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*